Hatteras Venture Advisors Iv Sbic, Llc - Net Worth and Insider Trading
Hatteras Venture Advisors Iv Sbic, Llc Net Worth
The estimated net worth of Hatteras Venture Advisors Iv Sbic, Llc is at least $3 Million dollars as of 2024-05-20. Hatteras Venture Advisors Iv Sbic, Llc is the of Clearside Biomedical Inc and owns about 2,060,514 shares of Clearside Biomedical Inc (CLSD) stock worth over $3 Million. Details can be seen in Hatteras Venture Advisors Iv Sbic, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hatteras Venture Advisors Iv Sbic, Llc has not made any transactions after 2017-01-19 and currently still holds the listed stock(s).
Transaction Summary of Hatteras Venture Advisors Iv Sbic, Llc
Hatteras Venture Advisors Iv Sbic, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hatteras Venture Advisors Iv Sbic, Llc owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Clearside Biomedical Inc (CLSD) .
Insider Ownership Summary of Hatteras Venture Advisors Iv Sbic, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2017-05-22 | 10 percent owner |
| CLSD | Clearside Biomedical Inc | 2017-01-19 | 10 percent owner |
Hatteras Venture Advisors Iv Sbic, Llc Latest Holdings Summary
Hatteras Venture Advisors Iv Sbic, Llc currently owns a total of 1 stock. Hatteras Venture Advisors Iv Sbic, Llc owns 2,060,514 shares of Clearside Biomedical Inc (CLSD) as of January 19, 2017, with a value of $3 Million.
Latest Holdings of Hatteras Venture Advisors Iv Sbic, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLSD | Clearside Biomedical Inc | 2017-01-19 | 2,060,514 | 1.31 | 2,699,273 |
Holding Weightings of Hatteras Venture Advisors Iv Sbic, Llc
Hatteras Venture Advisors Iv Sbic, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Hatteras Venture Advisors Iv Sbic, Llc has made a total of 0 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years. The most-recent trade in Clearside Biomedical Inc is the sale of 29,656 shares on January 19, 2017, which brought Hatteras Venture Advisors Iv Sbic, Llc around $255,931.
Insider Trading History of Hatteras Venture Advisors Iv Sbic, Llc
- 1
Hatteras Venture Advisors Iv Sbic, Llc Trading Performance
GuruFocus tracks the stock performance after each of Hatteras Venture Advisors Iv Sbic, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hatteras Venture Advisors Iv Sbic, Llc is 19.94%. GuruFocus also compares Hatteras Venture Advisors Iv Sbic, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hatteras Venture Advisors Iv Sbic, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hatteras Venture Advisors Iv Sbic, Llc's insider trading performs compared to the benchmark.
Performance of Hatteras Venture Advisors Iv Sbic, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.88 | | | | | |
| Relative Return to S&P 500(%) | -1.21 | | | | | |
Hatteras Venture Advisors Iv Sbic, Llc Ownership Network
Hatteras Venture Advisors Iv Sbic, Llc Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Hatteras Venture Advisors Iv Sbic, Llc is the 10 percent owner of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Hatteras Venture Advisors Iv Sbic, Llc made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,059 shares made by Rajesh Malik , a net sale of 122,272 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,620 shares made by Terry L Murdock .
In summary, during the past 3 months, insiders sold 84,560 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 84,560 shares. During the past 18 months, 320,099 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 320,099 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Hatteras Venture Advisors Iv Sbic, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Hatteras Venture Advisors Iv Sbic, Llc. You might contact Hatteras Venture Advisors Iv Sbic, Llc via mailing address: 280 S. Mangum Street, Suite 350, Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
